gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Vaccine-primed EBV-specific CD8+ T cells recognize EBV peptide–HLA class I on tumor cells and kill them via cytotoxic T-cell mechanisms (perforin/granzyme, Fas–FasL).
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
On
gated
Off
other_modifier
Naturally processed EBV epitopes loaded onto autologous APCs; recognized by CD8+ TCRs in an HLA-A/B/C–restricted manner
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05707910
disease_id_num_tar_ref
1706
drug_id_num_tar_ref
4618